Cerebral malaria is associated with IgG2 and IgG4 antibody responses to recombinant Plasmodium falciparum RIFIN antigen

This publication has 29 references indexed in Scilit:

• Protection against Clinical Malaria by Heterologous Immunoglobulin G Antibodies against Malaria‐Infected Erythrocyte Variant Surface Antigens Requires Interaction with Asymptomatic Infections
  The Journal of Infectious Diseases, 2004
• Plasmodium falciparum Infection Elicits Both Variant-Specific and Cross-Reactive Antibodies against Variant Surface Antigens
  Infection and Immunity, 2003
• Recognition of Variant Rifin Antigens by Human Antibodies Induced during Natural Plasmodium falciparum Infections
  Infection and Immunity, 2002
• High Prevalence of Human Antibodies to Recombinant Duffy Binding-Like α Domains of the Plasmodium falciparum -Infected Erythrocyte Membrane Protein 1 in Semi-Immune Adults Compared to That in Nonimmune Children
  Infection and Immunity, 2001
• Antibodies to Variant Antigens on the Surfaces of Infected Erythrocytes Are Associated with Protection from Malaria in Ghanaian Children
  Infection and Immunity, 2001
• Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 ofPlasmodium falciparum
  Infection and Immunity, 2001
• Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-l
  The Journal of Infectious Diseases, 1996
• Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.
  The Journal of Experimental Medicine, 1990
• Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: Functional role of IgG subclasses
  Research in Immunology, 1990
• The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor.
  The Journal of Experimental Medicine, 1984